Go Back to People
Michael Schmertzler joined Kolltan in 2008 and is the company's Chief Executive Officer. Mr. Schmertzler is also the chairman of the board of PTC Therapeutics, Inc., a director of Cytokinetics, Inc. and Segway Inc., chair of the Investment Committee of Credit Suisse First Boston Equity Partners, chair of the Board of the National Outdoor Leadership School and a trustee of Phillips Academy Andover. He has been an adjunct professor in the Yale School of Management since 1997 and a lecturer in the Yale University Department of Economics since 2005. Mr. Schmertzler has previously had senior responsibility for the management of approximately $5 billion of committed capital as co-head of Private Equity at Credit Suisse First Boston in the United States and president of the Morgan Stanley Private Equity Funds. He has also served as a managing director in Morgan Stanley's Mergers and Acquisitions Department and as founder of that firm's biotechnology investment banking practice and as manager of its worldwide investment banking insurance practice. Prior to joining Morgan Stanley, Mr. Schmertzler served as head of International Investment Banking and Sales and Trading, chief financial officer, chief administrative officer as well as managing director of Lehman Brothers Kuhn Loeb and its successor company. Mr. Schmertzler was previously a member of the executive committee and a governor of the New York Academy of Sciences. Mr. Schmertzler holds a B.A. in city planning, history and molecular biophysics and biochemistry from Yale College; attended the Woodrow Wilson School at Princeton University; and has an M.B.A. from Harvard Business School.
Michael Schmertzler
Chief Executive Officer & PresidentMichael Schmertzler joined Kolltan in 2008 and is the company's Chief Executive Officer. Mr. Schmertzler is also the chairman of the board of PTC Therapeutics, Inc., a director of Cytokinetics, Inc. and Segway Inc., chair of the Investment Committee of Credit Suisse First Boston Equity Partners, chair of the Board of the National Outdoor Leadership School and a trustee of Phillips Academy Andover. He has been an adjunct professor in the Yale School of Management since 1997 and a lecturer in the Yale University Department of Economics since 2005. Mr. Schmertzler has previously had senior responsibility for the management of approximately $5 billion of committed capital as co-head of Private Equity at Credit Suisse First Boston in the United States and president of the Morgan Stanley Private Equity Funds. He has also served as a managing director in Morgan Stanley's Mergers and Acquisitions Department and as founder of that firm's biotechnology investment banking practice and as manager of its worldwide investment banking insurance practice. Prior to joining Morgan Stanley, Mr. Schmertzler served as head of International Investment Banking and Sales and Trading, chief financial officer, chief administrative officer as well as managing director of Lehman Brothers Kuhn Loeb and its successor company. Mr. Schmertzler was previously a member of the executive committee and a governor of the New York Academy of Sciences. Mr. Schmertzler holds a B.A. in city planning, history and molecular biophysics and biochemistry from Yale College; attended the Woodrow Wilson School at Princeton University; and has an M.B.A. from Harvard Business School.